J&J acquires Listerine

The August edition of Retail Pharmacy reports that "Johnson and Johnson has recently announced that it has entered into a definitive agreeement to acquire Pfizer Consumer Healthcare for $16.6 billion in cash".

Brands that J&J will now own include Nicorette smoking cessation treatments and Listerine. The addition of Listerine alone, is reported to triple J&J's oral healthcare business to a franchise worth more than $US 1 billion and a presence in over 60 markets.